Beta Bionics, Inc. (BBNX) Stock Overview
Explore Beta Bionics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Beta Bionics, Inc. (BBNX)
Key Financials
Key Financials
Market Cap
577.2M
P/E Ratio
-7.99
EPS (TTM)
$-1.51
ROE
-0.26%
BBNX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Beta Bionics, Inc. (NASDAQ: BBNX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Beta Bionics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BBNX on the NASDAQ shows an RSI of 30.02, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $29.44 for the NASDAQ listing.
Key metrics behind Beta Bionics, Inc.'s NASDAQ-traded stock include a P/E ratio of -7.99 and a market capitalization of 577.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BBNX on the NASDAQ.